The pharmacology and clinical outcomes of amphetamines to treat ADHD: does composition matter? - Wikidata - awgldk - TriplyDB

The pharmacology and clinical outcomes of amphetamines to treat ADHD: does composition matter?

The pharmacology and clinical outcomes of amphetamines to treat ADHD: does composition matter?

http://www.wikidata.org/entity/Q37983613

about

Risk of stroke in prescription and other amphetamine-type stimulants use: A systematic review.Methamphetamine intoxication in a dog: case report.A systematic review of the safety of lisdexamfetamine dimesylate.The neuropeptide Y Y1 receptor knockdown modulates activator protein 1-involved feeding behavior in amphetamine-treated rats.Lisdexamfetamine Dimesylate Effects on the Pharmacokinetics of Cytochrome P450 Substrates in Healthy Adults in an Open-Label, Randomized, Crossover Study The Efficacy and Safety of Evekeo, Racemic Amphetamine Sulfate, for Treatment of Attention-Deficit/Hyperactivity Disorder Symptoms: A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled Crossover Laboratory Classroom Study A post hoc comparison of the effects of lisdexamfetamine dimesylate and osmotic-release oral system methylphenidate on symptoms of attention-deficit hyperactivity disorder in children and adolescents.Efficacy and safety of lisdexamfetamine dimesylate and atomoxetine in the treatment of attention-deficit/hyperactivity disorder: a head-to-head, randomized, double-blind, phase IIIb study.The use of lisdexamfetamine dimesylate for the treatment of ADHD and other psychiatric disorders.A review of OROS methylphenidate (Concerta(®)) in the treatment of attention-deficit/hyperactivity disorder.Lisdexamfetamine: A Review in ADHD in Adults.Expert Opinion and Recommendations for the Management of Attention-Deficit/Hyperactivity Disorder in Correctional Facilities.Factors Influencing the Cardiovascular Response to Subanesthetic Ketamine: A Randomized, Placebo-Controlled Trial.

P2860

Q30234520-9F1BF2DF-B235-4B19-A8F6-0BC74718070C Q30582283-D6A34DA9-4A23-4938-A366-1435FA141785 Q33755396-E6F12587-4B2B-4F1B-BD00-8DA4582E0D1A Q34480148-87D54274-0098-4B4A-A508-1A6C6BA8CD8B Q35807351-0E03A05A-084F-4FFB-9D6D-D99DC01A28C9 Q35816558-D3CCB379-E33A-4AB1-8816-5F6ED33AF94E Q37115696-598F914C-F74F-44A9-8A18-86AC584AE568 Q37330660-53C63EB3-E275-41F4-ABE1-E25B09C44F85 Q38221823-AFFF1F25-0F63-434F-B9E1-06E352F971D7 Q38239633-B5070EDF-0B3A-42A1-826B-656BF73A2CFA Q38799006-562FD210-A5D9-4C13-AF5F-0DA6C94EF6F0 Q40207289-5BED3DA2-A3A1-45F9-B2DF-E2A66DFACE7F Q47129607-70AD4F58-EDAE-48F4-9052-B6172D1BBDEE

P2860

The pharmacology and clinical outcomes of amphetamines to treat ADHD: does composition matter?

http://www.wikidata.org/entity/Q37983613

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

The pharmacology and clinical ...... ADHD: does composition matter?

@en

The pharmacology and clinical ...... ADHD: does composition matter?

@nl

type

label

The pharmacology and clinical ...... ADHD: does composition matter?

@en

The pharmacology and clinical ...... ADHD: does composition matter?

@nl

prefLabel

The pharmacology and clinical ...... ADHD: does composition matter?

@en

The pharmacology and clinical ...... ADHD: does composition matter?

@nl

P1433

Q37983613-DE0E4FAE-F4CD-4389-9E03-D031919A8780

P1476

Q37983613-22B82E29-77A6-4D0C-8BD8-C0F4339707C9

P2093

Q37983613-1BEF468E-5DE9-4E47-B62D-032947D6B5AD

Q37983613-1D7B9FAD-6BDD-4985-AF35-32DDD644864F

Q37983613-423A0C8C-5365-4AF4-BE18-0D52C868047A

Q37983613-44CF9DD7-AF7F-4CA0-B214-007086B191B9

P2860

Q37983613-03958727-CF70-4800-8CE1-7F14E7FADF8F

Q37983613-051F003E-A301-4A27-839B-38089E83530C

Q37983613-072EA812-CBE1-42E4-8CB8-723D51782B5A

Q37983613-0868D64A-299C-42F4-BC5F-1E8753DDBD3F

Q37983613-08E651A4-2D8A-4EEB-BCA9-05D311BF59B2

Q37983613-0CEF1CFE-5CD8-44C1-B641-C341644439AC

Q37983613-123E5CC6-EFDF-4A7E-985B-B19DA99DCC28

Q37983613-162AE7CF-A68B-490D-8E5D-F0DD3802F6AD

Q37983613-21271F1D-4A03-4055-A4BE-9A7E05266AAC

Q37983613-231C0CF0-50B1-4294-ABF9-DA592EB93944

P2888

Q37983613-79683FB9-A13C-429F-BE61-CE2EE4140387

P304

Q37983613-44BD40E4-B9C2-4725-A903-4EC55E278514

P31

Q37983613-3E571A1B-3357-44C2-A309-D13DE72535A7

P356

Q37983613-1599B8C4-2657-4DB9-A047-EA68753E334B

P433

Q37983613-77188992-1905-4604-AB9E-9CF9F02DA525

P478

Q37983613-72CEEC68-8553-4618-A34A-EA1E6697D1C5

P577

Q37983613-9D53B38B-5188-438A-85E4-D4F6A18F891A

P6179

Q37983613-48A6383C-C421-4560-ADD2-CCDB9E822133

P698

Q37983613-0241E7A1-25ED-4C61-AF2A-4335B03D7658

P921

Q37983613-3724C92E-E850-4CA9-BDDC-ECD71588F017

P356

11599630-000000000-00000

P1433

P1476

The pharmacology and clinical ...... ADHD: does composition matter?

@en

P2093

Floyd R Sallee

http://www.w3.org/2001/XMLSchema#string

Monica Shaw

http://www.w3.org/2001/XMLSchema#string

Paul Hodgkins

http://www.w3.org/2001/XMLSchema#string

Suzanne McCarthy

http://www.w3.org/2001/XMLSchema#string

P2860

The Worldwide Prevalence of ADHD: A Systematic Review and Metaregression Analysis

3-Year Follow-up of the NIMH MTA Study

Practice Parameter for the Assessment and Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder

Pharmacokinetic Determinants of Drug Abuse and Dependence

Methamphetamine toxicity and messengers of death

Abuse liability and safety of oral lisdexamfetamine dimesylate in individuals with a history of stimulant abuse

A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents

The marital and family functioning of adults with ADHD and their spouses.

Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment.

Placebo-controlled evaluation of amphetamine mixture-dextroamphetamine salts and amphetamine salts (Adderall): efficacy rate and side effects.

P2888

11599630-000000000-00000

P304

245-268

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2165/11599630-000000000-00000

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P577

2012-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1042377017

http://www.w3.org/2001/XMLSchema#string

P698

22329564

http://www.w3.org/2001/XMLSchema#string

P921